In Canada, apo-semaglutide is indicated as a once-weekly treatment for adults with Type 2 diabetes to improve glycemic ...
Canada’s prescription drug market just entered a new phase in the GLP-1 boom. After years of Ozempic dominating conversations ...
Apotex Inc. ("Apotex" or the "Company"), the largest Canadian‑based global health company, today announced the commercial launch of Apo‑Semaglutide Injection™ – a generic equivalent ...
Generic versions of semaglutide, popularly known as Ozempic, will soon be available in Canadian pharmacies.
Dr Reddy’s generic semaglutide launch in Canada signals cheaper obesity treatment and intensifying global competition against ...
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
An astonishing new trial suggests that Ozempic may help users not only drop pounds but also turn back time. In the first trial to directly measure the impact of semaglutide on aging, half of the ...